{"id":10516,"date":"2025-12-22T11:37:55","date_gmt":"2025-12-22T06:07:55","guid":{"rendered":"https:\/\/indianpharmanetwork.co.in\/medicines\/?post_type=product&#038;p=10516"},"modified":"2026-05-19T19:27:40","modified_gmt":"2026-05-19T13:57:40","slug":"emrelis-telisotuzumab-vedotin-tllv-supplier-india","status":"publish","type":"product","link":"https:\/\/indianpharmanetwork.co.in\/medicines\/product\/emrelis-telisotuzumab-vedotin-tllv-supplier-india\/","title":{"rendered":"EMRELIS (telisotuzumab vedotin-tllv) for injection"},"content":{"rendered":"<h4>What is EMRELIS?<\/h4>\n<p>EMRELIS is a prescription medicine used to treat adults with non-squamous non-small cell lung cancer (NSCLC):<\/p>\n<ul>\n<li>that has spread to areas near the lungs (locally advanced) or to other parts of the body (metastatic), and<\/li>\n<li>whose tumors have high c-Met protein overexpression, and<\/li>\n<li>who have received a prior treatment.<\/li>\n<\/ul>\n<p>Your healthcare provider will perform a test to make sure EMRELIS is right for you. It is not known if EMRELIS is safe and effective in children<\/p>\n<p><strong>EMRELIS (telisotuzumab vedotin-tllv) for injection, for intravenous use Initial U.S. Approval: 2025<\/strong><\/p>\n<h4>Is EMRELIS (telisotuzumab vedotin-tllv) available in India?<\/h4>\n<p><strong>EMRELIS (telisotuzumab vedotin-tllv) may be accessed in India through a named-patient import process<\/strong>\u00a0with a valid doctor\u2019s prescription, and\u00a0<strong>Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing<\/strong>\u00a0and delivery of specialty medicines subject to regulatory approvals.<\/p>\n<h4>How to get EMRELIS injection delivered in India?<\/h4>\n<p><strong>Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations.<\/strong>\u00a0Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.<\/p>\n<p><strong>IPN having representation in<\/strong>\u00a0Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.<\/p>\n<h4>Who can help source EMRELIS injection in India legally?<\/h4>\n<p><strong>Named-patient import facilitator contact details<\/strong><br \/>\n<strong>Company Name:<\/strong>\u00a0Indian Pharma Network (IPN)<br \/>\n<strong>Address:<\/strong>\u00a060\/4 1st Floor, T&amp;T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016<br \/>\n<strong>For sourcing and import coordination of specialty medicines, contact:<\/strong><br \/>\n<strong>Mr. Tarun:<\/strong>\u00a0+91 9891 296 838<br \/>\n<strong>Mr. Neeraj:<\/strong>\u00a0+91 9811 747 774<br \/>\n<strong>Email:\u00a0<a href=\"mailto:info@indianpharmanetwork.co.in\" target=\"_blank\" rel=\"noopener\">info@indianpharmanetwork.co.in<\/a><\/strong><\/p>\n<p><em>Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.<\/em><\/p>\n<h4>NEWS \/ UPDATES<\/h4>\n<ul>\n<li><a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-telisotuzumab-vedotin-tllv-nsclc-high-c-met-protein-overexpression\" target=\"_blank\" rel=\"noopener\">FDA grants accelerated approval to telisotuzumab vedotin-tllv for NSCLC with high c-Met protein overexpression.<\/a><\/li>\n<li><a href=\"https:\/\/news.abbvie.com\/2025-05-14-U-S-FDA-Approves-EMRELIS-TM-telisotuzumab-vedotin-tllv-for-Adults-With-Previously-Treated-Advanced-Non-Small-Cell-Lung-Cancer-NSCLC-With-High-c-Met-Protein-Overexpression\" target=\"_blank\" rel=\"noopener\">U.S. FDA Approves EMRELIS\u2122 (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression<\/a><\/li>\n<\/ul>\n<p><em><strong>Note:<\/strong><\/em><br \/>\n<em>We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.\u00a0<a href=\"https:\/\/indianpharmanetwork.co.in\/about-ipn.php\">Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<h2>Brand Name: EMRELIS. Generic Name: (telisotuzumab vedotin-tllv). It is used to treat Non-small cell lung cancer (NSCLC).<\/h2>\n<p>EMRELIS (telisotuzumab vedotin-tllv) is a prescription medicine used to treat adults with a specific type of non-small cell lung cancer (NSCLC) that has spread (locally advanced or metastatic).<\/p>\n<table border=\"1\" width=\"95%\">\n<tbody>\n<tr>\n<td><strong>Brand Name:<\/strong><\/td>\n<td>EMRELIS<\/td>\n<\/tr>\n<tr>\n<td><strong>Generic Name:<\/strong><\/td>\n<td>(telisotuzumab vedotin-tllv) for injection<\/td>\n<\/tr>\n<tr>\n<td><strong>Strength:<\/strong><\/td>\n<td>\u2022 For injection: 20 mg or 100 mg of telisotuzumab vedotin-tllv as a lyophilized powder in a single-dose vial.<\/td>\n<\/tr>\n<tr>\n<td><strong>Manufacturer:<\/strong><\/td>\n<td>AbbVie Inc<\/td>\n<\/tr>\n<tr>\n<td><strong>Approved By:<\/strong><\/td>\n<td>EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source Details:\u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/761384s000lbl.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Patient Information<\/strong><\/a><\/p>\n<p><em><strong data-sider-select-id=\"0264f273-b082-496a-b3a6-36bbf779f0ec\">IPN, New Delhi can facilitate patient to import of \u201cEMRELIS (telisotuzumab vedotin-tllv) for injection\u201d<\/strong>\u00a0in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please\u00a0<a href=\"mailto:urgent@indianpharmanetwork.co.in\" target=\"_blank\" rel=\"noopener\">email IPN healthcare Support Team\u00a0<\/a>for<strong>\u00a0pharma product<\/strong>\u00a0cost in India. on\u00a0<strong>Mr. Tarun:- +91 9891 296 838 \/ Mr. Neeraj:- +91 9811 747 774.<\/strong><\/em><\/p>\n","protected":false},"featured_media":10521,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":""},"product_brand":[],"product_cat":[170],"product_tag":[],"class_list":{"0":"post-10516","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-lung","8":"first","9":"instock","10":"shipping-taxable","11":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product\/10516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media\/10521"}],"wp:attachment":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media?parent=10516"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_brand?post=10516"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_cat?post=10516"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_tag?post=10516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}